Abstract              Background: The metabolic syndrome (MS) is described as clusters of abnormalities including abdominal obesity, insulin resistance, hypertension, hyperglycaemia, increased triglycerides, and decreased high-density lipoprotein cholesterol (HDL-C). Material and Method: All the patients aged > 18 years with newly detected Type 2 Diabetes Mellitus (< 6 months duration) admitted in Krishna institute of Medical Sciences. Classifying patients in four groups as (1) NCEP - ATP III, (2) Modified NCEP ATP III, (3) Modified WHO, (4)IDF - Presence of Central Obesity with waist circumference > 90 cm men and > 80 cm. Sample size: 100 patients. Results: Modified NCEP ATP III predicted MS in 60 patients (70%) and IDF criteria predicted MS in 40 (46%) patients which is least compared to others. Modified WHO and NCEP ATP III criteria’s were predicting MS 55(64%), 48(56%) respectively. Mean age of male is 47.23±9.82, mean age of female is 49.68±10.71, mean age of all cases is 48.60±10.48 comparing this age among male and female Z = 1.10, p>0.05.Mean and S.D of age (male) is 48.1±10.23. Mean and S.D of age (female) is 49.63±11.2. Mean age of all patients is 49.15 comparing this age among male and female Z - 0.53, p>0.05.By analyzing various individual parameters of MS in newly detected DM patients, high Triglycerides were present in 68(79%) patients(male-39,female-29) followed by raised SBP in 58(67.4%) patients(male-29, female-29). High fasting blood glucose was present in 55 patients, low HDL in 53 patients. Significant WC, waist hip ratio and significant BMI was seen in 44,40 and 40 patients respectively Conclusion: Modified NCEP ATP III criteria predicts highest occurrence of MS in newly detected type 2 DM patients. Elevated serum TG for men and decreased HDL for women were strongest single predictors, effectively indicating the presence of MS in newly detected type 2 DM patients.

Key Words: Diabetes mellitus type2, duration of diabetes, metabolic syndrome.